CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont.

Shulzhenko, Natalia; Dong, Xiaoxi; Vyshenska, Dariia; Greer, Renee L; Gurung, Manoj; Vasquez-Perez, Stephany; Peremyslova, Ekaterina; Sosnovtsev, Stanislav; Quezado, Martha; Yao, Michael; Montgomery-Recht, Kim; Strober, Warren; Fuss, Ivan J; Morgun, Andrey

Shulzhenko, Natalia; Dong, Xiaoxi; Vyshenska, Dariia; Greer, Renee L; Gurung, Manoj; Vasquez-Perez, Stephany; Peremyslova, Ekaterina; Sosnovtsev, Stanislav; Quezado, Martha; Yao, Michael; Montgomery-Recht, Kim; Strober, Warren; Fuss, Ivan J; Morgun, Andrey.

Afiliación

Shulzhenko N; College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States. Electronic address: Natalia.shulzhenko@oregonstate.edu.
Dong X; College of Pharmacy, Oregon State University, Corvallis, OR, United States.
Vyshenska D; College of Pharmacy, Oregon State University, Corvallis, OR, United States.
Greer RL; College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States.
Gurung M; College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States.
Vasquez-Perez S; College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States.
Peremyslova E; College of Pharmacy, Oregon State University, Corvallis, OR, United States.
Sosnovtsev S; Laboratory of Infectious Diseases, NIAID, United States.
Quezado M; Surgical Pathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Yao M; Mucosal Immunity Section, NIAID, National Institutes of Health, Bethesda, MD, United States; Washington DC VA Medical Center, Washington DC, United States.
Montgomery-Recht K; Mucosal Immunity Section, NIAID, National Institutes of Health, Bethesda, MD, United States; Clinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute,United States.
Strober W; Mucosal Immunity Section, NIAID, National Institutes of Health, Bethesda, MD, United States.
Fuss IJ; Mucosal Immunity Section, NIAID, National Institutes of Health, Bethesda, MD, United States.
Morgun A; College of Pharmacy, Oregon State University, Corvallis, OR, United States. Electronic address: andriy.morgun@oregonstate.edu.

Clin Immunol ; 197: 139-153, 2018 12.

Article en En | MEDLINE | ID: mdl-30240602

Asunto(s)

Inmunodeficiencia Variable Común/inmunología; Duodenitis/inmunología; Microbioma Gastrointestinal/inmunología; Inmunidad Mucosa/inmunología; Inmunoglobulina A/inmunología; Interferones/inmunología; Síndromes de Malabsorción/inmunología; Acinetobacter baumannii; Inmunodeficiencia Variable Común/complicaciones; Regulación hacia Abajo; Duodenitis/etiología; Duodenitis/microbiología; Femenino; Microbioma Gastrointestinal/genética; Expresión Génica; Humanos; Inflamación; Metabolismo de los Lípidos/genética; Síndromes de Malabsorción/etiología; Síndromes de Malabsorción/microbiología; Masculino; ARN Bacteriano/genética; ARN Ribosómico 16S/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina A / Interferones / Inmunodeficiencia Variable Común / Inmunidad Mucosa / Duodenitis / Microbioma Gastrointestinal / Síndromes de Malabsorción Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google